Aethlon Medical Inc
NASDAQ:AEMD
Aethlon Medical Inc
Goodwill
Aethlon Medical Inc
Goodwill Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Goodwill | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Aethlon Medical Inc
NASDAQ:AEMD
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Goodwill
$26.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
14%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Goodwill
$18.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Stryker Corp
NYSE:SYK
|
Goodwill
$19.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
17%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Goodwill
$24B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
10%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Goodwill
$370.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
|
Aethlon Medical Inc
Glance View
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. The company is headquartered in San Diego, California and currently employs 10 full-time employees. The firm operates through two segments: Aethlon and ESI. The Aethlon segment represents its therapeutic business activities. The ESI segment represents its diagnostic business activities. The firm's product, Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The Aethlon Hemopurifie is designed for the single-use removal of exosomes and life-threatening viruses from the human circulatory system. In cancer, the Aethlon Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression, seed the spread of metastasis. The Company, through its subsidiary Exosome Sciences, Inc. (ESI) is developing exosome-based biomarkers in patients with, or at risk for, a number of cancers.
